Need Training?

Build a solid foundation in science, formulation and product development—find out more!

Most Popular in:

Active

Email This Item! Print This Item!

Creatine and Carnitine for Treating Skin Pigmentation

Posted: March 27, 2007

page 2 of 2

Avicena Group Inc. is a late stage biotechnology company that develops products based on knowledge of the regulation of cellular energy processes. The company’s technologies have applications in pharmaceuticals and dermaceuticals. Avicena presently derives revenue from the sale of proprietary ingredients to skin care manufacturers. According to the group, this patent enhances the company's skin care patent portfolio, which also featured US Patent No. 6,242,491, with claims directed to methods for treating skin damage resulting from sun radiation, stress, fatigue or free radicals, by administering creatine.

"We are extremely pleased to have received this additional patent claim to broaden our IP position in dermaceuticals," stated Belinda Tsao-Nivaggioli, PhD, Avicena’s chief executive officer, in a press statement.  She added that this discovery that a composition of creatine and carnitine is an effective treatment for uneven skin pigmentation provides a new approach to a common dermatological problem.